{
    "answer": "Cosentyx's immunology segment full year 2024 net sales were USD 50.3 billion (+11%, +12% constant currency) compared to a reported +10% (+7% constant currency) in Q1 2024, which was part of full year 2024 guidance.",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 3,
    "search count": 1,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        866,
        2862,
        3736
    ]
}